Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019

Ítems similars

• Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
  per: Piagnerelli, Michaël, et al.
  Publicat: (2020)
• Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019
  per: Piagnerelli, Michaël, et al.
  Publicat: (2020)
• Urinary Neutrophil Gelatinase-Associated Lipocalin in Critically Ill Patients With Coronavirus Disease 2019
  per: Komaru, Yohei, et al.
  Publicat: (2020)
• The treatment of extracorporeal organ support for critical ill patients with coronavirus disease 2019: A brief perspective from the front line
  per: Lang, Yuheng, et al.
  Publicat: (2020)
• Timing of Intubation and Its Implications on Outcomes in Critically Ill Patients With Coronavirus Disease 2019 Infection
  per: Matta, Atul, et al.
  Publicat: (2020)